Authors


Mary G. Burke, MD

Latest:

The Impact of Screen Media on Children

In essence, screen media constitute neurologically potent, arousing input to the developing brain. Unlike conventional toxins, their effects are mediated by sense organs. However, they have demonstrable effects on brain activity, and on behavior and function.


Mary Margaret Gleason, MD

Latest:

Collaborative and Integrated Care in Pediatrics: Part of the Solution to the Child Mental Health Crisis

In this CME, learn more about implementing formal or informal collaboration with the primary care clinicians with whom you share care of your child patients.


Mary Mcaweeney, PhD

Latest:

The Substance Abuse Handbook

The Substance Abuse Handbook offers a comprehensive, clinically oriented approach to the treatment of addictive disorders. It contains a wealth of useful information, ranging from causes of addiction to different modes of treatment.


Mary Roessel, MD

Latest:

Next Steps: Solutions and Recommendations For Healing

Climate change is a devastating existential threat that can exaggerate preexisting inequities and health/mental health problems. As mental health professionals committed to understanding deep emotional wounds and addressing complexities of relationships, psychiatrists have the tools to assist in bridging the current gaps.


Mary S. Esther, MD

Latest:

Sleep Disturbances with Substances of Abuse and Dependence

Sleep disorders and substance abuse disorders are widespread acrossthe United States, researchers have found. According to the NationalCommission on Sleep Disorders Research, more than 80 million Americanscomplain of sleep difficulties, while Schuckit and Irwin reportedthe lifetime prevalence of alcohol abuse or dependence to be 13percent and nonalcohol drug abuse, 5.9 percent.


Mary T. Thigpen, PhD

Latest:

Developing Clinical Evidence for Locomotor Training

Locomotor training is an emerging rehabilitation intervention to help patients who have spinal cord injuries or who are recovering from stroke walk again. The basis for the intervention lies in understanding the neurobiology of walking and the nervous system's capacity for activity-dependent plasticity.


Mary V. Seeman, MDCM, DSc

Latest:

When Eating Disorders and Psychosis Co-Exist: 6 Take Home Points

The body image disturbance at the heart of anorexia nervosa is a false perception akin to the perceptual disorders found in schizophrenia.


Marya Morozova

Latest:

Understanding the Neurobiological Basis of Drug Abuse: Comorbidity in Schizophrenia

It is clear that the prognosis for schizophrenia is much better when patients achieve drug abstinence, including in the domains of depression, quality of life, and community integration.


Maryam Sharif-Razi

Latest:

Schizophrenia, Neurocognitive Dysfunction, and Substance-Related Disorders: A Review

The authors evaluate the effects of nicotine and cannabis on neurocognitive function in individuals with schizophrenia and review potential pharmacological treatment strategies.


Maryland Pao, MD

Latest:

Psychiatrists as Partners in Suicide Prevention for Pediatric Medical Settings

"The death rate among youth aged 10 to 24 years increased 52.2% from 6.9 per 100,000 in 2001 to 10.5 per 100,000 in 2020."


Matcheri S. Keshavan, MD

Latest:

Developing a Collaborative Approach to Post-Acute Sequelae of SARS-CoV-2 Infection

1 in 3 COVID-19 survivors experience persistent consequences. What can psychiatry do to help?


Matilde Inglese, MD, PhD

Latest:

The Role of MRI in the Diagnosis of Multiple Sclerosis

Multiple sclerosis (MS) is the most commoninflammatory demyelinating disease of theCNS and the most frequent cause of nontraumaticneurological disability in young andmiddle-aged adults.1 Women are twice as likelyto be affected as men, and onset typicallyoccurs between the ages of 20 and 40 years.


Matt G. Kushner, PhD

Latest:

Substance Abuse Screening in Patients With Anxiety Disorders

How can clinicians reliably identify comorbid drug and alcohol use disorders in patients with anxiety disorders?


Matt Goldenberg, DO

Latest:

Patient Education: 11 Common Questions on Heroin Abuse

A guide for helping patients understand heroin, its history, and how it impacts our communities.


Matthew A. Menza, MD

Latest:

Psychiatric Symptoms Associated With Parkinson Disease

Parkinson disease (PD) is the second most common neurodegenerative illness in the United States, affecting more than 1 million persons. Disease onset is usually after age 50. In persons older than 70 years, the prevalence is 1.5% to 2.5%.1 While the primary pathology involves degeneration of dopaminergic neurons in the substantia nigra, circuits important in emotion and cognition-such as the serotonergic, adrenergic, cholinergic, and frontal dopaminergic pathways-are also variably disrupted.


Matthew D. Erlich, MD

Latest:

Addressing the Aftermath of Suicide: Why We Need Postvention

Here: a brief review of the literature on postvention efforts; the effects on the victim’s caregivers; and a guide to resources to help manage survivors’ and caregivers’ emotions and dread.


Matthew J. Friedman, MD, PhD

Latest:

Addressing Postdeployment Needs

Although we would all like to believe otherwise, war is not over when a service member returns home. For many, returning home may be where the harder battles begin. Intensive training prepares troops for warfare, but what training do they have to readjust when they return home?


Matthew L. Goldman, MD

Latest:

Improving Mental Health Care in America: An Opportunity for Comprehensive Reform

The authors outline the ingredients for the transformation of mental health care in America.


Matthew M. Parvin, MD

Latest:

Unmasking Comorbid Pyromania and Psychosis in a Patient With Anorexia

Although psychosis is rare in adolescent patients with anorexia nervosa restricting type, the possibility should be explored because it may be the underlying cause of the eating disorder.


Matthew O. Hurford, MD

Latest:

Cognitive Rehabilitation in Schizophrenia

This article reviews methods to rehabilitate cognition in schizophrenia and suggests strategies for instituting a cognitive remediation program.


Matthew Parra, MD

Latest:

That’s Not My Child: A Case of Capgras Syndrome

The specific cause of Capgras syndrome has been hypothesized from neuropsychological and psychodynamic views.


Matthew S. Kayser, MD, PhD

Latest:

Psychiatric Presentations of Autoimmune Encephalopathies

Given the potential for a significant role in recognition of neurologically complex disorders, psychiatrists should become familiar with diagnostic criteria and appropriate therapeutic option.


Matthew W. State, MD, PhD

Latest:

Autism: Where Do We Go From Here?

In the last 5 years, there has been an absolutely profound transformation in the ability to identify genes that contribute to autism and schizophrenia.


Maureen Czick, MD

Latest:

Depression and Anxiety in Cardiac Disease

Here: a look at the associations between negative psychological states and CV health, physiologic and health behavior mechanisms, and ways to diagnose and treat depression and anxiety disorders.


Maureen Hakske-Palomino, MSN, NP-BC

Latest:

Clinical Pearls on the Management of Parkinson Disease

The ideal medication for Parkinson disease (PD) would reduce disability and halt or slow disease progression without intolerable adverse effects. Although such an agent is not yet available, current treatments offer significant symptom control for most patients. The decision about when to start therapy is highly individual; however, delaying treatment because of fear of adverse effects may not be in the patient's best interest.


Maureen Murdoch, MD, MPH

Latest:

Sexual Assault Among Male Veterans

Little attention has been paid to the prevalence of sexual assault and its sequelae among military men. The past-year prevalence of sexual assault among enlisted men ranges from 0.4% to 3.7%, a figure equal to or exceeding the lifetime prevalence among civilian men in some studies. Increased awareness and understanding of male sexual assault as well as routine screening of all patients, regardless of gender, for exposure to sexual victimization will enhance their recovery.


Mauricio Arcos-burgos Md, PhD

Latest:

Frontiers in Psychiatric Research

These are exciting times for genetics research: Science magazine chose our new appreciation of human genetic diversity as the scientific breakthrough of the year 2007.1 The year brought a new genetic bonanza with the announcement of the 1000 Genome Project, a plan to capture human diversity by obtaining the entire genome sequence information of 1000 individuals.


Mauricio Tohen, MD

Latest:

Comorbidity in Bipolar Disorder

The central tenet of clinical comorbidity, the occurrence of 2 syndromes in the same patient, presupposes that they are distinct categorical entities.


Maurizio Pompili, MD, PhD

Latest:

Mini Quiz: Violence and Psychosis

What percentage of patients hospitalized for a first episode of schizophrenia who had threatened others had displayed overt signs of illness for over a year?


Max Day, MD

Latest:

Learning to Do Psychotherapy With Psychotic Patients: In Memory of Elvin Semrad, MD

Dr Elvin Semrad was a much-loved psychiatrist and psychotherapy supervisor who had a profound influence on hundreds of psychotherapists and psychoanalysts in the Boston area. One of his unique qualities was his ability to connect empathically with even the most psychotic patients. He supervised at Boston State Hospital and then for 4 decades at the Massachusetts Mental Health Center (MMHC) in Boston, where he conveyed his strong conviction that psychotic and other seriously men-tally ill patients could benefit from long-term psychoanalytically oriented psychotherapy.

© 2025 MJH Life Sciences

All rights reserved.